Community-Centered Patient Journey Map in Opioid Use Disorder: A Tool to Address Compassion Fatigue among Community Pharmacists

被引:3
|
作者
Hohmeier, Kenneth Charles [1 ]
Cernasev, Alina [1 ]
Leibold, Christina [1 ]
Moore, Todd M. [2 ]
Schlesinger, Erica [3 ]
Cochran, Gerald [4 ]
Arce, Ileana [3 ]
Geminn, Wesley [3 ]
Chisholm-Burns, Marie [5 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Clin Pharm & Translat Sci, Nashville, TN 37211 USA
[2] Univ Tennessee, Dept Psychol, Knoxville, TN 37996 USA
[3] Tennessee Dept Mental Hlth & Subst Abuse Serv, Nashville, TN 37243 USA
[4] Univ Utah, Div Epidemiol, Salt Lake City, UT 84112 USA
[5] Oregon Hlth & Sci Univ, Off Provost, Portland, OR 97239 USA
关键词
pharmacist; addiction; medications for opioid use disorder; community pharmacy; UNITED-STATES; HEROIN USE; PERCEPTIONS; ATTITUDES;
D O I
10.3390/pharmacy11020052
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Community pharmacists have become increasingly exposed to opioid use disorders in recent decades. However, both pharmacist training and traditional practice environments have not been adequate to prepare the pharmacist for both the patient care needs and regulatory barriers of patients experiencing opioid use disorders (OUD). As a result, there is a need to increase pharmacists' awareness of both the overall patient experience as they navigate their OUD and the role of the community pharmacy as a touchpoint within that experience. To this end, a Community-Centered Patient Journey in Drug Addiction Treatment journey map was developed with expert insights, clinical experience, and in-depth interviews (conducted in spring of 2021) with 16 participants enrolled in licensed opioid treatment programs in Tennessee. Patients, policymakers, clinicians, and academic researchers were involved in the map development. Lived experiences of key informants were captured via in-depth interviews. A consensus decision-making approach was used throughout the patient journey map development process. The final patient journey map illustrates a non-linear pathway, describes the central role of the patient's community, and emphasizes three major "pain points" within the system (access, adherence, and affordability). Future research should investigate the impact of such a journey map on pharmacy personnel's knowledge, attitudes, and behaviors.
引用
收藏
页数:16
相关论文
共 33 条
  • [1] Community Pharmacists' Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder
    Lehr, Victoria Tutag
    Nolan, Claire
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (04) : E224 - E231
  • [2] A patient and community-centered approach selecting endpoints for a randomized trial of a novel advance care planning tool
    Bridges, John F. P.
    Crossnohere, Norah L.
    Schuster, Anne L.
    Miller, Judith A.
    Pastorini, Carolyn
    Aslakson, Rebecca A.
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 241 - 249
  • [3] Patient and Community Factors Affecting Treatment Access for Opioid Use Disorder
    Bulgin, Dominique
    Patrick, Stephen W. W.
    McElroy, Tamarra
    McNeer, Elizabeth
    Dupont, William D. D.
    Murry, Velma McBride
    OBSTETRICS AND GYNECOLOGY, 2023, 142 (02): : 339 - 349
  • [4] DEVELOPMENT OF A MYASTHENIA GRAVIS PATIENT JOURNEY MAP AS A TOOL TO IDENTIFY CHALLENGES AND UNMET NEEDS IN THE PATIENT COMMUNITY
    Howard, James F., Jr.
    Arbogast, Margaret
    Perlee, Lorah
    Lum, Ching
    Hartford, Christopher
    Pavani, Rodrigo
    Sellati, Rosemarie
    MUSCLE & NERVE, 2024, 70 (03) : 634 - 634
  • [5] Independent community pharmacists' attitudes and intentions toward dispensing buprenorphine/naloxone for opioid use disorder
    Zalmai, Rana
    Hill, Lucas G.
    Loera, Lindsey J.
    Mosgrove, Quinn
    Brown, Carolyn
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (05) : 1558 - 1565.e4
  • [6] Leveraging neuroscience education to address stigma related to opioid use disorder in the community: a pilot study
    Kyzar, Evan J.
    Arbuckle, Melissa R.
    Abba-Aji, Adam
    Balachandra, Krishna
    Cooper, Joseph
    Dela Cruz, Adriane
    Edens, Ellen
    Heward, Brady
    Jibson, Michael
    Jordan, Ayana
    Moreno-De-Luca, Daniel
    Pazderka, Hannah
    Singh, Mohit
    Weleff, Jeremy J.
    Yau, Bernice
    Young, Justin
    Ross, David A.
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [7] Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice
    Kelley, A. Taylor
    Incze, Michael A.
    Baylis, Jacob D.
    Calder, Spencer G.
    Weiner, Saul J.
    Zickmund, Susan L.
    Jones, Audrey L.
    Vanneman, Megan E.
    Conroy, Molly B.
    Gordon, Adam J.
    Bridges, John F. P.
    SUBSTANCE ABUSE, 2022, 43 (01) : 1286 - 1299
  • [8] Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees
    Hoffman, Lauren A.
    Vilsaint, Corrie L.
    Kelly, John F.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 131
  • [9] Gender differences among persons entering medication treatment for opioid use disorder in the community
    Di Paola, Angela
    Taweh, Noor
    Biondi, Breanne E.
    Foray, Ariadna
    Frank, Cynthia A.
    Shaw, Albert
    Springer, Sandra A.
    AMERICAN JOURNAL ON ADDICTIONS, 2022, 31 (05): : 390 - 395
  • [10] Project lifeline pilot: implementing SBIRT in rural community pharmacies to address opioid overdoses and substance use disorder
    Cloutier, Renee M.
    Talbert, Abigail
    Weidman, Joseph
    Pringle, Janice L.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2023, 18 (SUPPL 1):